Some reports suggest that inhibition of the EGFR pathway can reestablish oxidative metabolism associated with a decrease in glycolytic markers as well as lactate production, limiting fuel for tumor cell proliferation [12,58]. This evidence concerns the gene EGFR and neoplasm.